ADHD Treatment

ADHD Treatment Billing Services

ADHD care combines testing, recurring med management, therapy, and some of the most authorization-heavy prescriptions in medicine. We keep the whole revenue cycle moving, from first evaluation to every monthly refill visit.

96130-96138 Testing Code Expertise
Stimulant PA Workflow Managed
Telehealth Compliance Tracked

Why Is ADHD Billing Harder Than It Looks?

ADHD practices run on recurring revenue, monthly visits, ongoing prescriptions, periodic re-evaluation. That recurrence is a strength, but it also means one broken billing pattern repeats itself every month across the whole panel.

๐Ÿงช

Testing Code Complexity

ADHD evaluations mix 90791 or E/M interviews with testing evaluation (96130-96131) and administration codes (96136-96139), each in timed units with payer-specific caps. Billing the wrong combination, or more units than authorized, denies the highest-value encounter in the treatment cycle.

๐Ÿ’Š

Stimulant Prior Authorization

Controlled-substance prescriptions face pharmacy PAs, step therapy, quantity limits, and annual formulary resets. Every stalled authorization is a patient off medication and a follow-up visit that doesn't happen, clinical harm and lost revenue in one.

๐Ÿ”

High-Frequency Follow-Up Visits

Monthly titration visits and quarterly stable-phase check-ins generate steady E/M volume that payers monitor with frequency edits. Documentation has to support the cadence, or routine follow-ups become routine denials.

๐Ÿ“ก

Telehealth Rules in Motion

Much of modern ADHD care is virtual, and the rules for prescribing stimulants via telehealth have been extended in increments rather than settled permanently. Practices need someone tracking DEA policy, state rules, and payer billing requirements simultaneously.

RCM Built for ADHD-Focused Practices

We bill for ADHD-focused psychiatry practices, telehealth ADHD platforms, psychology practices running testing programs, and pediatric and adult ADHD clinics. The recurring-visit economics of ADHD care are exactly where disciplined billing compounds.

Our team keeps the evaluation, testing, prescription, and follow-up revenue streams each running clean, month after month.

  • Testing unit management, correct 96130-96138 combinations billed within payer unit caps, with authorization secured where required
  • Stimulant PA operations, pharmacy prior authorizations worked daily with complete clinical documentation packages
  • Frequency-edit defense, med management visits documented and billed to withstand payer frequency review
  • Telehealth compliance, POS and modifier accuracy for virtual visits, with controlled-substance rules tracked as they evolve
Clinician discussing ADHD treatment with patient

Pediatric and Adult ADHD Billing

Pediatric and adult ADHD care bill differently, different rating scales, different payer scrutiny, and different visit patterns. We handle both sides of the practice.

  • Pediatric workflows, Vanderbilt scales via 96127, parent-interview documentation, and coordination-of-care time captured correctly
  • Adult evaluations, comprehensive testing batteries billed with correct evaluation and administration unit splits
  • Combined treatment billing, E/M plus psychotherapy add-on coding when med management and therapy happen in one visit
  • Comorbidity coding, accurate ICD-10 sequencing when ADHD presents alongside anxiety, depression, or learning disorders
500+ Providers Served Nationwide
96.8% Net Collection Rate
24 Days Average AR Days
99% Clean Claim Rate Target

Frequently Asked Questions

Related Services

Behavioral Health RCM Psychiatry Billing Prior Authorization Medical Coding Denial Management
Comprehensive ADHD evaluations typically combine a diagnostic interview (90791 or an E/M visit) with psychological testing codes: 96130-96131 for testing evaluation services by the psychologist or physician, and 96136-96139 for test administration and scoring. Brief rating scales like the Vanderbilt or Conners completed in routine visits can be billed with 96127. Payers differ on how many testing units they allow for an ADHD evaluation and whether prior authorization is required.
Stimulant medications frequently require pharmacy prior authorization, step therapy documentation, and quantity-limit overrides, and requirements reset when plans change formularies each year. Our team manages the PA workflow with the documentation payers ask for, diagnosis support, treatment history, and prior medication trials, so prescriptions are not stranded at the pharmacy while patients wait.
Largely yes. Federal telehealth flexibilities have continued to allow prescribing stimulants via telehealth without a prior in-person visit, but the rules have been extended in increments and payer policies differ from federal policy. We track both layers, DEA/HHS rules and payer billing policies, and keep POS codes and modifiers compliant for virtual ADHD visits.
Medication management follow-ups, typically billed as 99213 or 99214, are generally covered monthly during titration and every 1-3 months when stable, but payer medical policies vary and some flag high-frequency visit patterns. We monitor payer frequency edits, document medical necessity for closer follow-up during dose changes, and keep recurring visit revenue clean and defensible.
Yes. Virtual-first ADHD practices carry concentrated compliance risk, multi-state licensure, state telehealth parity laws, and controlled-substance rules, alongside high visit volume. We bring the payer-rule infrastructure that lets virtual practices scale without building a billing department.
We integrate with behavioral health platforms including Valant, TherapyNotes, SimplePractice, and Osmind, plus general systems like athenahealth, AdvancedMD, and eClinicalWorks. Our technical team handles all integration setup at no additional cost.

Reviewed by the Revenue Synergy Editorial Team, AAPC- and AHIMA-credentialed RCM specialists. Last updated July 29, 2026.